Prominent publications by Stojan Z Peric'

KOL Index score: 14089

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic disease which can lead to many functional impairments, and like most other chronic disorders it might significantly affect quality of life (QoL). Information about QoL in patients with CIDP from developing countries is still lacking. We, therefore, sought to complete these data mosaic by investigating QoL in patients with CIDP from Serbia and surrounding countries. Our study comprised 106 patients diagnosed ...

Known for Chronic Inflammatory |  Patients Cidp |  Life Qol |  Physical Domains |  Illness Surveys
KOL Index score: 9468

Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK antibodies) presents a serious gap in MG diagnosis and understanding. Recently, autoantibodies against the low-density lipoprotein receptor-related protein 4 (LRP4) have been identified in several dSN-MG sera, but with dramatic frequency variation (∼2-50%). We have developed a cell based assay (CBA) based on human LRP4 expressing HEK293 cells, for the reliable and efficient detection of LRP4 antibodies. We ...

Known for Myasthenia Gravis |  Lrp4 Antibodies |  Positive Patients |  Hek293 Cells |  Achr Musk
KOL Index score: 9116

Myotonic dystrophy type 1 (DM1) is caused by a highly unstable expansion of CTG repeats in the DMPK gene. Its huge phenotypic variability cannot be explained solely by the repeat number. Recently, variant repeats within the DMPK expansions have emerged as potential disease modifiers. The frequency of variant expanded alleles was estimated in 242 DM1 patients from 174 Serbian families using repeat-primed PCR (RP-PCR). The patterns of variant repeats were determined by direct sequencing of ...

Known for Variant Repeats |  Dmpk Expansions |  Myotonic Dystrophy Type |  Atypical Symptoms |  Expanded Alleles
KOL Index score: 8886

CTG expansions in DMPK gene, causing myotonic dystrophy type 1 (DM1), are characterized by pronounced somatic instability. A large proportion of variability of somatic instability is explained by expansion size and patient's age at sampling, while individual-specific differences are attributed to additional factors. The age at onset is extremely variable in DM1, and inversely correlates with the expansion size and individual-specific differences in somatic instability. Three to five ...

Known for Repeat Interruptions |  Myotonic Dystrophy Type |  Age Onset |  Somatic Instability |  Dmpk Expansions
KOL Index score: 8696

AIM: To analyze quality of life (QoL) in a large cohort of myotonic dystrophy type 2 (DM2) patients in comparison to DM1 control group using both generic and disease specific questionnaires. In addition, we intended to identify different factors that might affect QoL of DM2 subjects.

PATIENTS AND METHOD: 49 DM2 patients were compared with 42 adult-onset DM1 patients. Patients completed SF-36 questionnaire and individualized neuromuscular quality of life questionnaire (INQoL). Following ...

Known for Myotonic Dystrophy Type |  Dm2 Patients |  Life Qol |  Muscle Strength |  Medical Council
KOL Index score: 8141

To date, generic questionnaires have been used to investigate quality of life (QoL) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients. Although these measures are very useful, they are not usually precise enough to measure all specific characteristics of the disease. Our aim was to investigate QoL using the neuromuscular disease-specific questionnaire (individualized neuromuscular quality of life, INQoL) in a large cohort of patients with CIDP. Our study ...

Known for Chronic Inflammatory |  Patients Cidp |  Life Qol |  Disability Score |  Physical Domains
KOL Index score: 8097

Amyotrophic lateral sclerosis (ALS) is characterized by weakness, fatigue, loss of balance and coordination. The purpose of the study was to examine gait in ALS patients. Gait was compared in ALS with spinal and bulbar onset, while performing dual mental and motor tasks. Dual-task walking was performed by 27 ALS patients, 13 with spinal- and 14 with bulbar-onset disease. Twenty-nine healthy subjects were used as a control group. The subjects performed a basic, simple walking task, ...

Known for Amyotrophic Lateral Sclerosis |  Task Walking |  Gait Pattern |  Postural Instability |  Dual Motor
KOL Index score: 7784

BACKGROUND: There is an unmet need for treatment options for generalised myasthenia gravis that are effective, targeted, well tolerated, and can be used in a broad population of patients. We aimed to assess the safety and efficacy of efgartigimod (ARGX-113), a human IgG1 antibody Fc fragment engineered to reduce pathogenic IgG autoantibody levels, in patients with generalised myasthenia gravis.

METHODS: ADAPT was a randomised, double-blind, placebo-controlled, phase 3 trial done at 56 ...

Known for Myasthenia Gravis |  Monoclonal Antibodies |  Receptor Antibody |  Humans Immunoglobulin |  Controlled Phase
KOL Index score: 7407

OBJECTIVE: To investigate grey (GM) and white matter (WM) abnormalities and their effects on cognitive and behavioral deficits in a large, phenotypically and genotypically well-characterized cohort of classic adult (aDM1, age at onset ≥ 20 years) or juvenile (jDM1, age at onset <20 years) patients with myotonic dystrophy type 1 (DM1).

METHODS: A case-control study including 51 DM1 patients (17 jDM1 and 34 aDM1) and 34 controls was conducted at an academic medical center. Clinical, ...

Known for Cognitive Impairment |  Myotonic Dystrophy |  Dm1 Patients |  Type 1 |  Wm Abnormalities
KOL Index score: 7251

Myasthenia gravis (MG) is an autoimmune disease caused by antibodies targeting the neuromuscular junction of skeletal muscles. Triple-seronegative MG (tSN-MG, without detectable AChR, MuSK and LRP4 antibodies), which accounts for ~10% of MG patients, presents a serious gap in MG diagnosis and complicates differential diagnosis of similar disorders. Several AChR antibody positive patients (AChR-MG) also have antibodies against titin, usually detected by ELISA. We have developed a very ...

Known for Titin Antibodies |  Myasthenia Gravis |  Neuromuscular Junction |  Serological Diagnosis |  Autoimmune Disease
KOL Index score: 7126

OBJECTIVE: To assess an impact of cognitive and behavioral impairment on QoL in a larger cohort of patients with DM1.

METHODS: Sixty six genetically confirmed DM1 patients (22 with juvenile (jDM1) and 44 with adult form (aDM1) of the disease) were recruited. Following behavioral tests were used: Hamilton scales for depression and anxiety (HamD and HamA), Daytime Sleepiness Scale (DSS), and Krupp's Fatigue Severity Scale (FSS). Patients also underwent detailed classic neuropsychological ...

Known for Myotonic Dystrophy Type |  Qol Patients |  Cognitive Impairment |  Quality Life |  Fatigue Severity
KOL Index score: 6990

Magnetic resonance imaging (MRI) of muscles has recently become a significant diagnostic procedure in neuromuscular disorders. There is a lack of muscle MRI studies in patients with myotonic dystrophy type 1 (DM1), especially type 2 (DM2). To analyze fatty infiltration of leg muscles, using 3.0 T MRI in patients with genetically confirmed DM1 and DM2 with different disease durations. The study comprised 21 DM1 and 10 DM2 adult patients. Muscle MRI was performed in axial plane of the ...

Known for Dm1 Dm2 |  Resonance Imaging |  Fatty Infiltration |  Muscles Patients |  Muscle Mri
KOL Index score: 6665

OBJECTIVE: To evaluate cardiac autonomic control in patients with myasthenia gravis (MG) and thymoma.

MATERIALS AND METHODS: The study was performed on 21 patients with MG and thymoma and the same number of matched healthy volunteers. Standard cardiovascular reflex tests according to Ewing and baroreflex sensitivity (BRS) at rest was applied. Spectral analysis of heart rate variability (HRV) at rest was assessed using a 20-minute ECG recording (normalized low- and high-frequency ...

Known for Myasthenia Gravis |  Cardiac Autonomic |  Hrv Rest |  Patients Thymoma |  Thymus Neoplasms
KOL Index score: 6618

OBJECTIVE: Guillain-Barre syndrome (GBS) is an acute disease of the peripheral nerves and their roots. Quality of life (QoL) in the first year after acute episode of GBS is still underresearched area. The aim of our study was to investigate QoL in GBS patients during a 6-month follow-up period.

METHODS: Multicentric, prospective study included 74 adult patients with GBS (54% males). GBS disability scale (GDS) was used to assess functional disability (severe disability GDS > 2), and ...

Known for Gbs Patients |  Life Qol |  Functional Disability |  Barre Syndrome |  Gds Scores


Stojan Z Peric': Influence Statistics

Sample of concepts for which Stojan Z Peric' is among the top experts in the world.
Concept World rank
dm2 fdgpet #1
cidp β #1
hypometabolism parietotemporal #1
1 type 2 #1
eds fatigue progression #1
detailed classic #1
worse sensory score #1
scores krupp #1
fdgpet dm1 #1
worse inqol #1
girdle quality #1
higher fatigue level #1
cidp chronic disease #1
dm1 amyotrophic #1
included dm1 subjects #1
adm1 severity #1
jdm1 adult age #1
mets myotonic #1
5983 ± 2698progression #1
female fluorodeoxyglucose p005 #1
executive dysfunction dm2 #1
patterns myotonic #1
shorter duration cidp #1
qol lgmd #1
dm2 fdg #1
patients striatal hypometabolism #1
mirs fatigue #1
nep cidp patients #1
pet naming #1
score lgmd #1
issue inflammatory demyelinating #1
dm1 executive #1
cantab life #1
dm2 diastolic #1
striatal hypometabolism p005 #1
variability multisystemic features #1
66 dm1 #1
hypometabolism p005 #1
demyelinating fatigue #1
dm1 17 #1
cardiac impairments patients #1
years fss score #1
64 dm1 patients #1
variability multisystemic #1
lgmd predictors #1
juvenile jdm1 #1
dm1 patients association #1
cidp patients nep #1
serbia surrounding #1
patients adm1 #1

Key People For Myotonic Dystrophy Type

Top KOLs in the world
Charles A Thornton
myotonic dystrophy skeletal muscle gene expression
Richard T III Moxley
myotonic dystrophy insulin receptor skeletal muscle
Peter S Harper
myotonic dystrophy huntington disease south wales
John David Brook
myotonic dystrophy human chromosome congenital heart disease
Giovanni Meola
myotonic dystrophy type skeletal muscle dm1 dm2
Helen G Harley
myotonic dystrophy chromosome 19 human pair

Stojan Z Peric':Expert Impact

Concepts for whichStojan Z Peric'has direct influence:Myotonic dystrophy type,  Myasthenia gravis,  Chronic inflammatory,  Myotonic dystrophy,  Dm2 patients,  Variant repeats,  Life qol,  Dm1 patients.

Stojan Z Peric':KOL impact

Concepts related to the work of other authors for whichfor which Stojan Z Peric' has influence:Myasthenia gravis,  Myotonic dystrophy type,  Pompe disease,  Chronic inflammatory,  Dm1 patients,  Neuromuscular junction,  Acetylcholine receptor.



Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

University of Belgrade, Faculty of Medicine, Dr Subotic Street 8, 11000, Belgrade, Serbia | University Clinical Center of Serbia, Neurology Clinic, Dr Subotic Street 6, 11000, Belgrade, Serbia | Faculty of Medicine, Neurology Clinic, University Clini

FREE Custom List